Today's episode features Deborah Mash, founder and CEO of DemeRx, a clinical stage company developing ibogaine therapies to treat substance use disorders.

In this episode, we discuss:

The science, experience and the safety behind Ibogaine’s “neurochemical reset”
Navigating US drug regulatory system and securing Intellectual Property
Deborah’s 30 journey through Amsterdam, Miami and the Caribbean aiming to get Ibogaine therapy approved
Partnership with ATAI Life Sciences

Links to topics discussed in this episode:
Deborah Mash
DemeRx
Ibogaine
Noribogaine
Tabernanthe Iboga
Bwiti Religion
Howard Lotsof
Serotonergics
Lambarene - promoted as a mental and physical stimulant
Habenula
Addiction Expert Gabor Maté

Read the transcript here.
Watch episode 8 on YouTube.
Created by Greg Kubin and Matias Serebrinsky
Host: Greg Kubin
Produced by Jonathan A. Davis & Zack Frank
Marketing by DaisyMae VanValkenburgh

Find us at businesstrip.fm
Follow us on Instagram and Twitter!

Theme music by Dorian Love
Additional music by Medita by Crowander, Two Feet by Muted Circus, and Rain On Me by JBlanked.

A 30 year journey towards ibogaine approval: Deborah Mash, CEO of DemeRx